https://orcid.org/0000-0003-3267-6606
References
- Marangos PJ, Campbell IC, Schmechel DE, et al. Blood platelets contain a neuron-specific enolase subunit. J Neurochem. 1980;34(5):1254–1258.
- Rodríguez-Rodríguez A, Egea-Guerrero JJ, Vilches-Arenas Á, et al. Effect of freezing-thawing process on neuron specific enolase concentration in severe traumatic brain injury sera samples. Clin Chem Lab Med. 2014;52:65–67.
- Ferraro S, Braga F, Luksch R, et al. Measurement of serum neuron-specific enolase in neuroblastoma: is there a clinical role? Clin Chem. 2020;66(5):667–675.
- Isgrò MA, Bottoni P, Scatena R. Neuron-Specific enolase as a biomarker: Biochemical and clinical aspects. Adv Exp Med Biol. 2015;867:125–143.
- Zandbergen EGJ, Hijdra A, Koelman JHTM, et al. Prediction of poor outcome within the first 3 days of postanoxic coma. Neurology. 2006;66(1):62–68.
- Callaway CW, Donnino MW, Fink EL, et al. Cardiac arrest care: 2015 american heart association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015;140:e881–e894.
- Rundgren M, Cronberg T, Friberg H, et al. Serum neuron specific enolase – impact of storage and measuring method. BMC Res Notes. 2014;7(1):726.
- Ramont L, Thoannes H, Volondat A, et al. Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice. Clin Chem Lab Med. 2005;43(11):1215–1217.
- Mastroianni A, Panella R, Morelli D. Invisible hemolysis in serum samples interferes in NSE measurement. Tumori. 2020;106(1):79–81.
- Verfaillie CJ, Delanghe JR. Hemolysis correction factor in the measurement of serum neuron-specific enolase. Clin Chem Lab Med. 2010;48(6):891–892.
- Tolan NV, Vidal-Folch N, Algeciras-Schimnich A, et al. Individualized correction of neuron-specific enolase (NSE) measurement in hemolyzed serum samples. Clin Chim Acta. 2013;424:216–221.
- Berger R, Richichi R. Derivation and validation of an equation for adjustment of neuron-specific enolase concentrations in hemolyzed serum. Pediatr Crit Care Med. 2009;10:260–263.
- Aarsand AK, Fernandez-Calle P, Webster C, et al. EFLM Biological Variation Database. [cited 2020 Sept]. Available from: https://biologicalvariation.eu/
- Planche V, Brochet C, Bakkouch A, et al. Importance of hemolysis on the neurospecific enolase assay (NSE). Ann Biol Clin. 2010;68:239–242.
- Vondrakova D, Kruger A, Janotka M, et al. Association of neuron-specific enolase values with outcomes in cardiac arrest survivors is dependent on the time of sample collection. Crit Care. 2017;21(1):172.
- Marques-Garcia F. Methods for hemolysis interference study in laboratory medicine – a critical review. EJIFCC. 2020;31(1):85–97.
- Johnsson P, Blomquist S, Lührs C, et al. Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation. Ann Thorac Surg. 2000;69(3):750–754.
- Belgian Official gazette. Royal decree concerning the recognition of the clinical biology laboratories by the Minister of Health. [cited 1999 Dec 3]. Available from: http://www.ejustice.just.fgov.be/eli/arrete/1999/12/03/1999024072/moniteur.
- Official Journal of the European Union. Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (Text with EEA relevance), 5-5-2017.